Synthesis and Biological Evaluation of Novel Phosphonyl Thiazolo Pyrazoles by Srinivas, Avula
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Synthesis and Biological 
Evaluation of Novel Phosphonyl 
Thiazolo Pyrazoles
Avula Srinivas
Abstract
A series of novel dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-
4-yl)methoxy)-3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-9-oxo-8-phenyl-
6-thia-1,2,8-triazaspiro[4.4]non-2-en-3-ylphosphonate 11a–g were synthesized 
by the reaction of chalcone derivatives of (E)-5-benzylidene-2-((2S,3S)-3-((1-
(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-3,6-dihydro-2H-pyran-2-yl)-
3-phenylthiazolidin-4-one 10a–g with Bestmann-Ohira reagent. The chemical 
structures of newly synthesized compounds were elucidated by IR, NMR, MS, and 
elemental analysis. The compounds 11a–g were evaluated for their nematicidal 
activity against Dietylenchus myceliophagus and Caenorhabditis elegans, and com-
pounds 11b, 11c, 11g, and 11f showed appreciable nematicidal activity.
Keywords: phosponylpyrazoles, Bestmann-Ohira reagent, click reaction, 
Knoevenagel condensation, cyclisation, nematicidal activity
1. Introduction
1,2,3-Triazoles are one of the most important classes of heterocyclic organic 
compounds, which are reported to present in a plethora of biological activities 
for diverse therapeutic areas [1–12]. The 1,2,3-triazole motif is associated with 
diverse pharmacological activities such as antibacterial, antifungal, hypoglycemic, 
antihypertensive and analgesic properties [13–15]. Polysubstituted five-membered 
aza heterocyclic’s rank the most potent glycosidase inhibitors [16–19]. Further, this 
nucleus in combination with or in linking with various other classes of compounds 
such as amino acids, steroids, aromatic compounds, carbohydrates etc. became 
prominent in having various pharmacological properties [20]. 1,2,3-Triazole modi-
fied carbohydrates have became easily available after the discovery of the Cu(I) 
catalyzed azide-alkynes 1,3-dipolar cycloaddition reaction [21–25] and quickly 
became a prominent class of non-natural sugars. The chemistry and biology of 
triazole modified sugars is dominated by triazole glycosides [26]. Therefore, the 
synthesis and investigation of biological activity of 1,2,3-triazole glycosides is an 
important objective, which also received the considerable attention by the medici-
nal chemists.
Thiazoles are familiar group of heterocyclic compounds possessing a wide 
variety of biological activities and their utility as medicine is very much estab-
lished [27]. Thiazole nucleus is also an integral part of all the available penicillins 
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which have revolutionized the therapy of bacterial diseases [28]. The chemistry of 
thiazolidinone ring system is one of considerable interest as it is the core structure 
in various synthetic pharmaceuticals displaying a broad spectrum of biological 
activities [29]. The thiazolidinone nucleus also appears frequently in the structure 
of various natural products notably thiamine, compounds possessing cardiac and 
glycemic benefits such as troglitazone [30] and many metabolic products of fungi 
and primitive marine animals, including 2-(aminoallyl)-thiazole-4-carboxylic acids 
[31]. Numerous thiazolidinone derivatives have shown significant bio activities 
such as antidiarrhoeal [32], anticonvulsant [33], antimicrobial [34], antidiabetic 
[35], antihistaminic [36], anticancer [37], anti HIV [38], Ca2+ channel blocker 
[39], PAF antagonist [40], cardioprotective [41], antiischemic [42], COX inhibi-
tory [43], antiplatelet activating factor [44], non-peptide thrombin receptor 
antagonist [45], tumor necrosis factor-α-antagonist [46] and nematicidal activities. 
Organophosphorus compounds continue to attract much attention because of their 
various potent biological activities [47, 48] in particular, phosphonates are impor-
tant synthetic derivatives which can have often act as phosphate and carboxylic 
acid mimics, and interfere with enzymatic processes. Much of this activity has 
been attributed to the relatively inert nature of the C▬P bond [47, 48], which is not 
easily hydrolyzed as compared to the P▬O bond found in phosphates. The syn-
thesis and biological activities of important natural and nonnatural phosphonate 
derivatives, including phosphonated aza heterocyclics and nucleotides, have been 
reviewed [49–51]. In view of the importance of heterocyclics bearing a phosphonate 
group, new synthetic methods that would allow straightforward access to these 
versatile building blocks are needed [47, 48, 52]. Among the various bioactive 
heterocyclics the pyrazole moiety remains of great interest because of its wide 
applications in the pharmaceutical and agrochemical industry [53, 54]. In addition, 
pyrazoles also play a central role in coordination chemistry [55].
Nematodes are tiny worms, some of them are plant parasites, and can play an 
important role in the predisposition of the host plant to the invasion by secondary 
pathogens [56]. Plants attacked by nematodes show retarded growth and develop-
ment, as well as loss in the quality and quantity of the harvest. The nematicide 
use is slated for reduction due to environmental problems, and human and animal 
health concern. For example, effective nematicides such as dibromochloropropane 
(DBCD) and ethylene dibromide (EDB) have been withdrawn from the market due 
to their deleterious effects on human and the environment. Methyl bromide, the 
most effective and widely used fumigant for soil borne pests including nematodes, 
has already been banned.
The use of nonfumigant nematicides, based on organophosphates and carba-
mates, is expected to increase the withdrawal of methyl bromide, which will bring 
about new environmental concerns. In fact, the highly toxic aldicarb used to control 
insects and nematodes has been detected in ground water [57]. Therefore alterna-
tive nematode control methods or less toxic nematicides need to be developed [58]. 
One way of searching for such nematicidal compounds is to screen naturally occur-
ring compounds in plants. Several such compounds, e.g., alkaloids, phenols, ses-
quiterpenes, diterpenes, polyacetylenes, and thienyl derivatives have nematicidal 
activity [59]. For example, α-terthienyl is a highly effective nematicidal compound 
[60]. Other compounds with nematicidal activity have been isolated from plants, 
mainly from the family Asteraceae [59]. However, compounds of plant origin and 
their analogs have not been developed into commercial nematicides; hence there is a 
need to develop commercial synthesis.
Following the successful introduction of nematicidal agents, inspired by the 
biological profile of triazoles, thiazoles, Phosponylpyrazoles. In continuation of 
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our work on biological active molecules [61–69] it was thought to interest to accom-
modate all those moieties in single molecular frame work. In this article we wish to 
report the synthesis of a new class of hybrid heterocyclic’s 11a–g in good yields and 
their evaluated nematicidal activity.
2. Result and discussion
The key intermediate, 8 required for the synthesis of title compound was 
prepared according to the procedure outlined in Figure 1. Diacetyl-D-glucal (2) 
prepared from 3,4,6-tri-O-acetyl D-glucal by treating with triethyl silane and boron 
trifluoride diethyl etherate, de acylation of 2, with NaOMe in methanol at 0°C for 
1 hour gave 3 (77%), which on subsequent treatment with TBDMSCl in dichloro-
methane in presence of NEt3 for 12 hours afforded TBS ether 4 (80%), on treatment 
with propargyl bromide in toluene in presence of tetra butyl ammonium hydrogen 
sulfate produced di ether 5. After deprotection of TBS ether the propargyl ether 
converted into triazole 7 (82%) by using 1,3-dipolar cycloaddition with p-chloro 
phenyl azide was carried out at ambient temperature in the presence of CuSO4 
and sodium ascorbate in a mixture of 1:1 CH2Cl2-H2O. Oxidation of 7 with IBX in 
Figure 1. 
R= (a) C6H5; (b) 4-Cl-C6H5; (c) 4-NO2-C6H5; (d) 2-CH3-C6H5; (e) 4-CH3-C6H5; (f) 3-OH-C6H5;  
(g) 2-OH-C6H5.
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acetonitrile afforded compound 8. Subsequently one pot synthesis of triazole linked 
thiazolidinone glycosides was carried out by the condensation reaction between 8, 
primary aromatic amine and a thio glycolic acid in presence of ZnCl2 under micro-
wave irradiation (Figure 1). The reaction is completed in only 5–10 minutes and the 
compounds, isolated by conventional work-up, (9a–g) are obtained in satisfactory 
yields, Compound 9a–g was then reacted with p-fluoro benzaldehyde in presence 
of anhydrous NaOAc in glacial AcOH at reflux temperature gave chalcone deriva-
tives of triazole linked thiazolidinone glycosides 10a–g, on cyclocondensation 
under conventional and microwave irradiation with Bestmann-Ohira reagent in 
presence of anhydrous KOH gave compounds 11(a–g). The structures of synthe-
sized compounds were confirmed by IR, NMR, MS and elemental analysis. Further 
the compounds were subject to nematicidal activity testing.
3. Nematicidal activity
The compounds synthesized 10a-g in this study were also screened for their 
nematicidal activity against Dietylenchus myceliophagus and Caenorhabditis elegans 
by aqueous in vitro screening technique [70] at various concentrations. The 
nematicidal activity of each test compound was compared with the standard drug 
Levamisole. The results have been expressed in terms of LD50 i.e., median lethal dose 
at which 50% nematodes became immobile (dead). The screened data reveal that, 
compounds 11b, 11c, 11f and 11g are the most effective against Dietylenchus myce-
liophagus and Caenorhabditis elegans the other test compounds showed moderate 
activity. The LD50 values of the test compounds screened are presented in Table 1.
4. Experimental
Commercial grade reagents were used as supplied. Solvents except analytical 
reagent grade were dried and purified according to literature when necessary. 
Di-methyl 2-oxopropyl phosphonate was purchased from Aldrich for the synthesis 
o Bestmann-Ohira reagent. Reaction progress and purity of the compounds were 
checked by thin-layer chromatography (TLC) on pre-coated silica gel F254 plates 
from Merck and compounds visualized either by exposure to UV light or dipping in 
1% aqueous potassium permanganate solution. Silica gel chromatographic columns 
Compound LD50 value (ppm)
D. myceliophagus C. elegans
11a 740 860
11b 220 280
11c 320 270
11d 501 540
11e 960 900
11f 209 210
11g 310 360
Levamisole 160 180
Table 1. 
Nematicidal activity of 11(a–g).
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(60–120 mesh) were used for separations. Optical rotations were measured on a 
Perkin-Elmer 141 polarimeter by using a 2 ml cell with a path length of 1 dm with 
CHCl3 or CDCl3 as solvent. All melting points are uncorrected and measured using 
Fisher-Johns apparatus. IR spectra were recorded as KBr disks on a Perkin-Elmer 
FTIR spectrometer. Micro wave reactions are carried out in mini lab microwave 
catalytic reactor (ZZKD, WBFY-201). The 1HNMR and 13C NMR spectra were 
recorded on a Varian Gemini spectrometer (300 MHz for 1H and 75 MHz for 13C).  
Chemical shifts are reported as δ ppm against TMS as internal reference and 
coupling constants (J) are reported in Hz units. Mass spectra were recorded on a 
VG micro mass 7070H spectrometer. Elemental analysis (C, H, N) determined by a 
Perkin-Elmer 240 CHN elemental analyzer, were within ±0.4% of theoretical.
((2R,3S)-3-acetoxy-3,6-dihydro-2H-pyran-2-yl)methyl acetate (2): Tri-O-
acetyl-D-glucal (1) (3.0 g, 11.02 mmol) was dissolved in anhydrous dichlorometh-
ane (5 ml). The solution was cooled to 0°C, triethyl silane (1.53 g, 13.22 mmol) was 
added and the mixture was stirred for 5 minutes. Next boron tri fluoride diethyl 
etherate (690 μl of a 40 w% solution in diethyl ether, 11.02 mmol) was added drop 
wise and the reaction mixture was stirred for 90 minutes. The mixture was poured 
into a saturated solution of NaHCO3. The organic layer was washed with water, 
dried over Na2SO4 and concentrated under reduced pressure. Column chromatog-
raphy on silica gel (PE/EtOAc, 3:1) yielded the title compound (2.24 g, 10.42 mmol, 
95%) as a colorless syrup. [α]D20: +115.5 (c = 1.00, CHCl3).
1H NMR (300 MHz, 
CDCl3): δ 5.87-5.84 (m, 2H, =CH),4.95 (t,1H, OCH),4.03-3.99 (m, 1H, CH),4.12-
4.09 (m,4H, OCH2), 2.20 (s, 6H, COCH3);
13C NMR (75 MHz, CDCl3): δ170.2, 127.2, 
125.8, 73.6, 65.1, 64.0, 62.5, 21.1; MS: m/z (M++H) 215. Anal. Calcd for C10H14O5: C, 
56.07; H, 6.59; Found: C, 55.82; H, 6.35.
(2R,3S)-2-((tert-butyldimethylsilyloxy)methyl)-3,6-dihydro-2H-pyran-
3-ol (4): Diacetate 2 (17.22 mmol) was treated by a catalytic amount of sodium 
methoxide in methanol (100 ml) at room temperature. After evaporation of the 
solvent, the free hydroxyl unsaturated glycoside was obtained in quantitative yield 
and used without further purification. This diol was treated with 2.50 equiv. of TBD 
MSCl (3.14 g, 21.14 mmol), 2.6 equiv. of NEt3 (3.2 ml, 22.4 mmol), and 0.05 equiv. 
of imidazole (30 mg, 0.43 mmol) in CH2Cl2 (30 ml) at room temperature for ca. 
24 hours (until TLC analysis showed no more starting material). After addition of 
25 ml of water and extraction with 3–30 ml of CH2Cl2, the organic layer was dried. 
After evaporation of the solvent under reduced pressure, the residue was puri-
fied by column chromatography using petroleum ether/ethyl acetate as the eluent 
yielded the title compound (1.94 g, 10.42 mmol, 85%) as a colorless syrup. 1H NMR 
(300 MHz, CDCl3): δ 6.0–5.82 (m, 2H, 〓CH), 5.42 (d, J = 6.5 Hz, 1H, CH),4.50 
(brs, 1H, OH), 4.20–4.12(m,1H, CH), 3.91–3.80(m,4H, CH2), 0.98 (s, 9H, t-Bu), 
0.24 (s, 6H, CH3); 
13C NMR (75 MHz, CDCl3): δ 127.5, 125.6, 84.6, 81.5, 73.6, 62.7, 
25.6, 18.1; MS: m/z (M++Na) 267. Anal. Calcd for C12H24O3Si: C, 58.97; H, 9.90; 
Found: C, 58.62; H, 9.75.
tert-butyldimethyl(((2R,3S)-3-(prop-2-ynyloxy)-3,6-dihydro-2H-pyran-2-yl)
methoxy)silane (5): To a solution of alcohol 4 (400 mg, 1.63 mmol, 1.0 equiv) in 
toluene (1.6 ml) was added a 35% aqueous solution of NaOH (1.6 ml), propargyl 
bromide (80% solution in toluene, 363 μl, 2.4 mmol, 1.5 equiv), and n-Bu4NHSO4 
(280 mg, 0.82 mmol, 0.5 equiv). After 6 hours of vigorous stirring at room tempera-
ture, Et2NH (1.6 ml) was added. The reaction mixture was stirred for 1 hour, poured 
into ice water, cautiously neutralized by addition of a 3 M solution of hydrochloric 
acid, and extracted with EtOAc. The combined organic extracts were washed with 
brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The 
crude material was purified by flash chromatography on silica gel (hexane/EtOAc 
85:15) to afford propargyl ether as colorless oil (0.345 g, 75%). 1H NMR (300 MHz, 
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CDCl3): δ 6.03–5.80 (m, 2H, 〓CH), 4.69 (t, J = 3.9 Hz 1H, CH), 3.68 (dd, J = 8.9 Hz, 
4.1 Hz, 1H, OCH), 3.99–3.89(m, 6H, CH2), 3.20 (s, 1H, CH), 0.96 (s, 9H, t-Bu), 0.23 
(s, 6H, CH3); 
13C NMR (75 MHz, CDCl3): δ 127.2, 124.9, 78.0, 76.2, 74.2, 64.2, 63.2, 
58.5, 25.3, 18.5; MS: m/z (M++H) 283. Anal. Calcd for C15H26O3Si: C, 63.78; H, 9.28; 
Found: C, 63.62; H, 8.95.
((2R,3S)-3-(prop-2-ynyloxy)-3,6-dihydro-2H-pyran-2-yl)methanol (6): 
To a stirred solution of 5 (0.325 g) in Tetra hydro furan catalytic amount of TBAF 
was added and stirred the reaction mixture at room temperature for 15 minutes, 
extracted the product with Ethyl acetate (20 ml). The combined organic extracts 
were washed with brine, dried over MgSO4, filtered, and concentrated under 
reduced pressure. The crude material was purified by flash chromatography on silica 
gel (60–120 mesh, hexane/EtOAc 70, 0) to afford alcohol as yellow oil (0.285 g, 85%) 
1H NMR (300 MHzCDCl3) 5.95–5.75 (m, 2H, 〓CH), 4.65(d, J = 3.9 Hz, 1H, CH), 4.52 
(brs, 1H, OH), 4.09–4.11 (m, 4H, OCH2), 3.64 (dd, J = 4.1 Hz, 8.9 Hz, 1H, OCH), 
3.76 (d, J = 6.8 Hz, 2H, OCH2), 3.28 (s, 1H, CH): 
13C NMR (75 MHz, CDCl3): δ 127.2, 
125.6, 78.3, 76.1, 74.1, 64.2, 61.4, 58.0; MS: m/z (M++H) 169. Anal. Calcd for C9H12O3: 
C, 64.27; H, 7.10; Found: C, 64.02; H, 6.95.
((2R,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-3,6-di-
hydro-2H-pyran-2-yl)methanol (7): To a solution containing alkyne 6 (0.250 g, 
0.778 mmol), p-chloro phenyl azide (0.130 g, 0.849 mmol) in dichloromethane 
(10 ml) and water (10 ml) were added CuSO4.5H2O (0.110 g) and sodium ascorbate 
(0.114 g). The resulting suspension was stirred at room temperature for 6 hours. 
After this time, the mixture was diluted with 5 ml dichloromethane and 5 ml water. 
The organic phase was separated, dried with sodium sulfate and concentrated at 
reduced pressure the crude product was purified by column chromatography on 
silica gel (60–120 mesh, hexane/EtOAc 65:35) to afford 7 (0.290 g, 75%) as a white 
powder. Mp: 149–1510°C. 1HNMR (300 MHz, CDCl3): δ8.05 (s, 1H, Ar-H), 7.56 (d, 
J = 9.2 Hz, 2H, Ar-H),7.45 (d, J = 8.9 Hz, 2H, Ar-H), 5.85–5.79 (m, 2H, 〓CH), 4.59 (s, 
2H, OCH2), 4.50 (brs, 1H, OH), 3.88–3.99 (m, 4H, OCH2), 3.8–3.75 (m, 2H, OCH): 
13CNMR (75 MHz, CDCl3): δ140.9, 134.5, 134.1, 128.4, 127.5, 125.4, 122.1, 11.5, 78.6, 
68.5, 65.7, 64.2, 62.4: MS: m/z (M++H) 322. Anal. Calcd for C15H16ClN3O3: C, 55.90; H, 
5.01, N, 13.06; Found: C, 55.65, H, 4.95. N, 12.86.
(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-3-phenylthiazolidin-4-one 9(a-g): To a solution 
of alcohol 7 (0.120 g, 0.465 mmol) in CH2Cl2 (5 ml), catalytic amount of IBX was 
added at 0°C and stirred at room temperature for 30 minutes. The reaction mixture 
was filtered and washed with CH2Cl2 (2 × 10 ml). It was dried (Na2SO4) and evapo-
rated to give aldehyde 7 (0.110 g) in quantitative yield as a yellow liquid, which was 
used as such for the next reaction.
To a stirred mixture of 8 (0.110 g, 0.373 mmol), aromatic amine (0.373 mmol) 
and anhydrous thioglycolic acid (0.140 g, 0.211 mmol) in dry toluene (5 ml), 
ZnCl2 (0.100 g, 0.751 mmol) was added after 2 minutes and irradiated in micro-
wave bath reactor at 280 W for 4–7 minutes at 110°C. After cooling, the filtrate 
was concentrated to dryness under reduced pressure and the residue was taken-up 
in ethyl acetate. The ethyl acetate layer was washed with 5% sodium bicarbon-
ate solution and finally with brine. The organic layer was dried over Na2SO4 and 
evaporated to dryness at reduced pressure. The crude product thus obtained was 
purified by column chromatography on silica gel (60–120 mesh) with hexane-
ethyl acetate as eluent.
(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)
methoxy)-3,6-dihydro-2H-pyran-2-yl)-3-phenylthiazolidin-4-one (9a): mp: 
157–159°C. Yield—75%. 1HNMR (300 MHz, CDCl3): δ8.04 (s, 1H, Ar-H), 7.50 
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(d, J = 9.2 Hz, 2H, Ar-H), 7.40 (d, J = 8.9 Hz, 2H, Ar-H), 7.10–6.20 (m, 5H, Ar-H), 
5.80–5.71 (m, 2H, 〓CH), 4.90 (d, J = 5.2 Hz, 1H, CH-S), 4.52 (s, 2H, OCH2), 
4.09–3.94 (m, 2XCH), 3.79 (d, J = 6.6 Hz, 2H, OCH2), 3.72 (s, 2H, CH2): 
13CNMR 
(75 MHz, CDCl3): δ170.4, 144.1, 141.8, 134.1, 128.2, 125.6, 122.4, 119.4, 85.6, 72.6, 
66.4, 64.0, 51.4, 33.9: MS: m/z (M++H) 469. Anal. Calcd for C23H21ClN4O3S: C, 58.91; 
H, 4.51, N, 11.95; Found: C, 58. 68, H, 4.35. N, 11.66.
(R)-3-(4-chlorophenyl)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-
triazol-4-yl)methoxy)-3,6-dihydro-2H-pyran-2-yl)thiazolidin-4-one (9b): mp: 
226–228°C Yield—69%. 1HNMR (300 MHz, CDCl3): 8.05 (s, 1H, Ar-H), 7.54 (d, 
J = 9.4 Hz, 4H, Ar-H), 7.42 (d, J = 8.6 Hz, 4H, Ar-H), 5.84–5.75 (m, 2H, 〓CH), 4.94 
(d, J = 5.2 Hz, CH-S), 4.50 (s, 2H, OCH2), 4.06–3.96 (m, 2H, 2XCH), 3.80 (t, 2H, 
OCH2), 3.72 (s, 2H, CH2): 
13CNMR (75 MHz, CDCl3): δ 170.5, 144.2, 139.2, 134.2, 
129.2, 125.5, 122.2, 119.4, 85.4, 72.8, 65.4, 63.4, 51.2, 34.1: MS: m/z (M++Na) 525. 
Anal. Calcd for C23H20Cl2N4O3S: C, 54.88; H, 4.00, N, 11.13; Found: C, 54.58, H, 
3.75. N, 10.86.
(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-3-(4-nitrophenyl)thiazolidin-4-one (9c): mp: 
211–213°C, Yield—71%. 1HNMR (300 MHz, CDCl3): δ8.26 (d, J = 8.7 Hz, 2H, Ar-H), 
8.03 (s, 1H, Ar-H), 7.61 (d, J = 9.4 Hz, 2H, Ar-H), 7.46 (d, J = 8.5 Hz, 2H, Ar-H), 6.84 
(d, J = 9.8 Hz, 2H, Ar-H), 5.86–5.79 (m, 2H, 〓CH), 4.96 (d, J = 5.2 Hz, CH-S), 4.55 
(s, 2H, OCH2), 4.05–3.95 (m, 2H, 2XCH), 3.85 (d, J = 6.9 Hz, 2H, OCH2), 3.82 (s, 2H, 
CH2): 
13CNMR (75 MHz, CDCl3): δ171.5, 144.0, 141.8, 134.2, 128.5, 125.4, 119.5, 85.4, 
72.4, 65.9, 63.6, 51.5, 34.6: MS: m/z (M++H) 514. Anal. Calcd for C23H20ClN5O5S:  
C, 53.75; H, 3.92, N, 13.63; Found: C, 53.58, H, 3.75. N, 13.39.
(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-3,6-di-
hydro-2H-pyran-2-yl)-3-o-tolylthiazolidin-4-one (9d): mp: 191–193°C, Yield—65%. 
1HNMR (300 MHz, CDCl3): δ8.08 (s, 1H, Ar-H), 7.56 (d, J = 9.2 Hz, 2H, Ar-H), 7.49 (d, 
J = 8.7 Hz, 2H, Ar-H), 7.45–7.39 (m, 4H, Ar-H), 5.76 (m, 2H, 〓CH), 4.93 (d, J = 5.2 Hz, 
1H, CHS), 4.60 (s, 2H, OCH2), 4.05–3.96 (m, 2H, CH), 3.90 (t, 2H, OCH2), 3.81  
(s, 2H, CH2), 2.1 (s, 3H, CH3): 
13CNMR (75 MHz, CDCl3): δ170.5, 144.2, 138.2, 134.2, 
130.7, 128.6, 125.6, 122.0, 119.5, 116.5, 85.4, 72.6, 65.8, 63.4, 52.0, 32.3, 17.5: MS: m/z 
(M++H) 483. Anal. Calcd for C24H23ClN4O3S: C, 59.68; H, 4.80, N, 11.60; Found: C, 
59.48, H, 4.55. N, 11.49.
(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-3-p-tolylthiazolidin-4-one (9e): mp: 195–198°C 
Yield—79%. 1HNMR (300 MHz, CDCl3): δ8.05 (s, 1H, Ar-H), 7.51 (d, J = 9.2 Hz, 
2H, Ar-H), 7.45 (d, J = 8.7 Hz, 2H, Ar-H), 7.25 (d, J = 8.2 Hz, 2H, Ar-H), 6.84  
(d, J = 9.4 Hz, 2H, Ar-H), 5.72–5.68 (m, 2H, 〓CH), 4.95 (s, 1H, CHS), 4.59 (s, 2H, 
OCH2), 4.04–3.99 (m, 2H, CH), 3.98 (t, 2H, OCH2), 3.90 (s, 2H, CH2), 2.32  
(s, 3H, CH3): 
13CNMR (75 MHz, CDCl3): δ170.5, 144.2, 138.6, 136.2, 14.1, 133.2, 
129.4, 127.5, 122.5, 119.5, 85.4, 72.0, 66.4, 63.5, 51.5, 34.0, 21.4: MS: m/z (M++H) 483. 
Anal. Calcd for C24H23ClN4O3S: C, 59.68; H, 4.80, N, 11.60; Found: C, 59.58, H, 4.65. 
N, 11.43.
(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-3-(3-hydroxyphenyl)thiazolidin-4-one (9f): mp: 
218–219°C, Yield—85%. 1H-NMR (300 MHz, CDCl3): δ9.40 (brs, 1H, Ph-OH), 8.08 
(s, 1H, Ar-H), 7.58 (d, J = 9.3 Hz, 2H, Ar-H), 7.49 (d, J = 8.6 Hz, 2H, Ar-H), 6.83–6.76 
(m, 4H, Ar-H), 5.72–5.68 (m, 2H, 〓CH), 4.94 (d, J = 5.2 Hz, 1H, CHS), 4.64 (s, 
2H, OCH2), 4.12 (t, 2H, OCH2), 4.01–3.94 (m, 2H, CH), 3.92 (s, 2H, CH2): 
13CNMR 
(75 MHz, CDCl3): δ 170.5, 158.2, 143.8, 134.5, 130.4, 128.6, 125.6, 122.4, 119.5, 
114.8, 106.5, 85.4, 72.5, 66.4, 63.4, 51.5, 34.1: MS: m/z (M++Na) 507. Anal. Calcd for 
C23H21ClN4O4S: C, 59.96; H, 4.36, N, 11.55; Found: C, 59.28, H, 4.65. N, 11.43.
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(R)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-3,6-di-
hydro-2H-pyran-2-yl)-3-(4-hydroxyphenyl)thiazolidin-4-one (9g): mp: 273–275°C, 
Yield—82%. 1H-NMR (300 MHz, CDCl3): δ9.42 (brs, 1H, Ph-OH), 8.05 (s, 1H, Ar-H), 
7.56 (d, J = 9.2 Hz, 2H, Ar-H), 7.46 (d, J = 8.4 Hz, 2H, Ar-H), 7.32 (d, J = 8.6 Hz, 2H, Ar- 
H), 7.02 (d, J = 8.8 Hz, 2H, Ar-H), 5.89–5.80 (m, 2H, 〓CH), 4.96 (d, J = 5.4 Hz,  
1H, CHS), 4.66 (s, 2H, OCH2), 4.09 (d, J = 2H, OCH2), 4.04–3.98 (m, 2H, CH), 3.94 
(s, 2H, CH2): 
13CNMR (75 MHz, CDCl3): δ170.9, 154.1, 144.4, 134.9, 134.8, 128.8, 127.2, 
125.6, 123.2, 119.4, 116.4, 85.4, 72.6, 66.5, 64.0, 51.6, 34.5: MS: m/z (M++H) 485. Anal. 
Calcd for C23H21ClN4O4S: C, 59.96; H, 4.36, N, 11.55; Found: C, 59.38, H, 4.75. N, 11.33.
General procedure for the synthesis of (10a-g): A mixture of compound 9a 
(0.01 mol), p-fluoro benzaldehyde (0.02 mol) and sodium acetate (0.01 mol) in 
anhydrous glacial acetic acid (20 ml), was refluxed for 3 hours. The reaction mix-
ture was concentrated and then poured into ice cold water, the solid thus separated, 
was filtered, washed with water and crystallized from glacial acetic acid. To afford 
pure 10a as yellow solid.
(R,Z)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)-3-phenylthiazolidin-4-one 
(10a): mp: 235–237°C, Yield—85%. 1HNMR (300 MHz, CDCl3): δ8.07 (s, 1H, 
Ar-H), 7.80 (s, 1H, CH〓C), 7.72 (d, J = 9.6 Hz, 2H, Ar-H), 7.40 (d, J = 9.2 Hz, 2H, 
Ar-H), 7.45 (d, J = 8.9 Hz, 2H, Ar-H), 7.19 (d, J = 8.2 Hz, 2H, Ar-H), 7.02–6.80  
(m, 5H, Ar-H), 5.80–5.74 (m, 2H, 〓CH), 4.90 (d, J = 5.2 Hz, 1H, CH▬S), 4.52 (s, 
2H, OCH2), 4.09–3.94 (m, 2H, 2XCH), 3.79 (d, J = 6.6 Hz, 2H, OCH2): 
13CNMR 
(75 MHz, CDCl3): δ170.4, 162.1, 144.1, 141.8, 139.8, 134.1, 130.4, 128.2, 125.6, 124.6, 
122.4, 119.4, 115.5, 85.6, 72.6, 66.4, 64.0, 51: MS: m/z (M++H) 575. Anal. Calcd for 
C30H24ClFN4O3S: C, 62.66; H, 4.21, N, 9.74; Found: C, 62. 48, H, 4.15. N, 9.56.
(R,Z)-3-(4-chlorophenyl)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-
triazol-4-yl)methoxy)-3,6-dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)
thiazolidin-4-one (10b): mp: 216–218°C. Yield—72%. 1HNMR (300 MHz, CDCl3): 
8.09 (s, 1H, Ar-H), 7.75 (s, 1H, CH〓C), 7.62 (d, J = 9.5 Hz, 2H, Ar-H), 7.52 (d, 
J = 9.4 Hz, 4H, Ar-H), 7.40 (d, J = 8.6 Hz, 4H, Ar-H), 7.19 (d, J = 8.1 Hz, 2H, Ar-H), 
5.84–5.75 (m, 2H, 〓CH), 4.94 (d, J = 5.2 Hz, 1H, CH-S), 4.52 (s, 2H, OCH2), 4.06–
3.94 (m, 2H, 2XCH), 3.80 (t, 2H, OCH2): 
13CNMR (75 MHz, CDCl3): δ170.5, 162.1, 
144.2, 139.2, 134.2, 130.4, 129.2, 125.5, 124.1, 122.2, 119.4, 85.4, 72.8, 65.4, 63.4, 51.2: 
MS:m/z(M++Na)632. Anal. Calcd for C30H23Cl2 FN4O3S: C, 59.12; H, 3.80, N, 9.19; 
Found: C, 59.01, H, 3.45. N, 8.96.
(R,Z)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)-3-(4-nitrophenyl)
thiazolidin-4-one (10c): mp: 221–223°C Yield—75%. 1HNMR (300 MHz, CDCl3): 
δ8.29 (d, J = 8.7 Hz, 2H, Ar-H), 8.09 (s, 1H, Ar-H), 7.69 (d, J = 9.1 Hz, 2H, Ar-H), 7.65 
(s, 1H, CH〓C), 7.61 (d, J = 9.4 Hz, 2H, Ar-H), 7.46 (d, J = 8.5 Hz, 2H, Ar-H), 7.18 (d, 
J = 8.3 Hz, 2H, Ar-H), 6.84 (d, J = 9.8 Hz, 2H, Ar-H), 5.86–5.79 (m, 2H, 〓CH), 4.96 
(d, J = 5.2 Hz, CH-S), 4.55 (s, 2H, OCH2), 4.05–3.95 (m, 2H, 2XCH), 3.85 (d, J = 6.9 Hz, 
2H, OCH2): 
13CNMR (75 MHz, CDCl3): δ171.5, 162.1, 144.0, 141.8, 134.2, 130.4, 
128.5, 125.4, 119.5, 115.4, 85.4, 72.4, 65.9, 63.6, 51.5: MS: m/z (M++H) 620. Calcd for 
C30H23ClFN5O5S: C, 58.11; H, 3.74, N, 11.29; Found: C, 57.98, H, 3.55. N, 11.09.
(R,Z)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)-3-o-tolylthiazolidin-
4-one (10d): mp: 201–203°C, Yield—85%. 1HNMR (300 MHz, CDCl3): δ8.08 (s, 
1H, Ar-H), 7.69 (d, J = 8.5 Hz, 2H, Ar-H), 7.62 (s, 1H, CH〓C), 7.56 (d, J = 9.2 Hz, 
2H, Ar-H), 7.49 (d, J = 8.7 Hz, 2H, Ar-H), 7.45–7.39 (m, 4H, Ar-H), 7.10  
(d, J = 9.1 Hz, 2H, Ar-H), 5.76 (m, 2H, 〓CH), 4.93 (d, J = 5.2 Hz, 1H, CHS), 4.60  
(s, 2H, OCH2), 4.05–3.96 (m, 2H, CH), 3.90 (t, 2H, OCH2), 2.1 (s, 3H, CH3): 
13CNMR (75 MHz, CDCl3): δ170.8, 162.9, 144.6, 137.2, 133.2, 130.6, 130.4, 128.2, 
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125.9, 122.7, 119.2, 116.2, 115.4, 84.4, 72.1, 65.3, 63.1, 52.5, 32.0, 17.5: MS: m/z 
(M++H) 589. Anal. Calcd for C31H26ClFN4O3S: C, 63.21; H, 4.45, N, 9.51; Found: C, 
62.75, H, 4.25. N, 9.29.
(R,Z)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)-3-p-tolylthiazolidin-4-one 
(10e): mp: 205–215°C, Yield—66%. 1HNMR (300 MHz, CDCl3): δ8.02  
(s, 1H, Ar-H), 7.69 (s, 1H, CH〓C), 7.65 (d, J = 9.1 Hz, 2H, Ar-H), 7.54 (d, J = 9.2 Hz, 
2H, Ar-H), 7.42 (d, J = 8.7 Hz, 2H, Ar-H), 7.35 (d, J = 8.2 Hz, 2H, Ar-H), 7.18 (d, 
J = 8.8 Hz, 2H, Ar-H), 6.80 (d, J = 9.4 Hz, 2H, Ar-H), 5.70–5.69 (m, 2H, 〓CH), 4.94 
(s, 1H, CHS), 4.55 (s, 2H, OCH2), 4.04–3.98 (m, 2H, CH), 3.96 (t, 2H, OCH2), 2.32 
(s, 3H, CH3): 
13CNMR (75 MHz, CDCl3): δ170.1, 162.5, 144.1, 139.5, 137.6, 135.2, 
133.2, 130.4, 129.1, 127.5, 124.1, 122.5, 119.5, 115.3, 85.1, 72.5, 66.1, 63.2, 51.2, 21.6: 
MS: m/z (M++H) 589. Anal. Calcd for C31H26ClFN4O3S: C, 63.21; H, 4.45, N, 9.51; 
Found: C, 62.98, H, 4.25. N, 9.33.
(R,Z)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-3,6-
dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)-3-(3-hydroxyphenyl)thiazolidin-
4-one (10f): mp: 218–219°C, Yield—82%. 1H-NMR (300 MHz, CDCl3): δ9.42 (brs, 1H, 
Ph-OH), 8.08 (s, 1H, Ar-H), 7.71 (d, J = 9.7 Hz, 2H, Ar-H), 7.65 (s, 1H, CH〓C), 7.59 
(d, J = 9.3 Hz, 2H, Ar-H), 7.44 (d, J = 8.6 Hz, 2H, Ar-H), 7.15 (d, J = 8.4 Hz, 2H, Ar 
-H), 6.80–6.78 (m, 4H, Ar-H), 5.70–5.68 (m, 2H, 〓CH), 4.92 (d, J = 5.2 Hz, 1H, CHS), 
4.64 (s, 2H, OCH2), 4.10 (t, 2H, OCH2), 4.01–3.98 (m, 2H, CH): 
13CNMR (75  
MHz, CDCl3): δ170.5, 162.1, 158.2, 143.8, 139.8, 134.5, 130.8, 128.6, 125.6, 124.1, 122.4, 
119.5, 115.7, 114.8, 106.5, 85.4, 72.5, 66.4, 63.4, 51.5: MS: m/z (M++H) 591. Anal. Calcd 
for C30H24ClFN4O4S: C, 60.96; H, 4.09, N, 9.48; Found: C, 60.58, H, 3.85. N, 9.13.
(R,Z)-2-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-5-(4-fluorobenzylidene)-3-(4-hydroxyphenyl)
thiazolidin-4-one (10g): mp: 283–285°C, Yield—62%. 1H-NMR (300 MHz,CDCl3): 
δ9.42 (brs, 1H, Ph-OH), 8.05 (s, 1H, Ar-H), 7.85 (d, J = 9.3 Hz, 2H, Ar-H), 7.65 (s, 
1H, CH〓C), 7.56 (d, J = 9.2 Hz, 2H, Ar-H), 7.46 (d, J = 8.4 Hz, 2H, Ar-H), 7.32  
(d, J = 8.6 Hz, 2H, Ar-H), 7.19 (d, J = 8.3 Hz, 2H, ArH), 7.02 (d, J = 8.8 Hz, 2H, 
Ar-H), 5.89–5.80 (m, 2H, 〓CH), 4.96 (d, J = 5.4 Hz, 1H, CHS), 4.66 (s, 2H, 
OCH2), 4.09 (d, J = 2H, OCH2), 4.04–3.98 (m, 2H, CH), 
13CNMR (75 MHz, CDCl3): 
δ170.9, 162.5, 154.1, 144.4, 139.8, 134.9, 134.8, 130.4, 128.8, 127.2, 125.6, 123.2, 
119.4, 116.4, 115.9, 85.4, 72.6, 66.5, 64.0, 51.6: MS: m/z (M++H) 591. Anal. Calcd for 
C30H24ClFN4O4S: C, 60.96; H, 4.09, N, 9.48; Found: C, 60.58, H, 3.95. N, 9.23.
General procedure for the synthesis of Pyrazole phosphonates (11a-g): To a 
stirred mixture of 10a (1 mmol), and Bestmann-Ohira Reagent (2.5 mmol) in dry EtOH 
(10 ml) was added KOH (2.5 mmol) at room temperature, after 2 minutes and irradi-
ated in microwave bath reactor at 500 W for 4–7 minutes at 50°C. The crude product 
thus obtained was purified by column chromatography on silica gel (60–120 mesh) 
with hexane-ethyl acetate as eluent. Under conventional method the reaction mixture 
in EtOH (10 ml) was stirred at room temperature for the appropriate time (Table 2).
Dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-9-oxo-8-phenyl-6-thia-1,2,8-
triazaspiro[4.4]non-2-en-3-ylphosphonate (11a): 245–247°C, Yield—75%. 1HNMR 
(300 MHz, CDCl3): δ13.06 (brs, 1H, 〓NH), 8.03 (s, 1H, Ar-H), 7.70 (d, J = 9.6 Hz, 
2H, Ar-H), 7.30 (d, J = 9.2 Hz, 2H, Ar-H), 7.45 (d, J = 8.9 Hz, 2H, Ar-H), 7.19 (d, 
J = 8.2 Hz, 2H, Ar-H), 6.95–6.70 (m, 5H, Ar-H), 5.80–5.74 (m, 2H, 〓CH), 4.80  
(d, J = 5.2 Hz, 1H, CH-S), 4.42 (s, 2H, OCH2), 4.09–3.94 (m, 2H, 2XCH), 3.78  
(s, 6H, OCH3), 3.69 (d, J = 6.6 Hz, 2H, OCH2), 3.52 (s, 1H, CH): 
13CNMR (75 MHz, 
CDCl3): δ170.1, 160.1, 155.2, 144.1, 141.6, 136.2, 134.1, 129.2, 127.5, 125.6, 122.1, 
119.1, 115.8, 86.6, 72.9, 63.8, 53.8, 44.5, 34.9: MS: m/z (M++H) 725. Anal. Calcd for 
C33H31ClFN6O6PS: C, 54.66; H, 4.31, N, 11.59; Found: C, 54.48, H, 4.05. N, 11.36.
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Dimethyl8-(4-chlorophenyl)-7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-
triazol-4-yl)methoxy)-3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-9-oxo-
6-thia-1,2,8-triazaspiro[4.4]non-2-en-3-ylphosphonate (11b): mp: 206–208°C, 
Yield—82%. 1HNMR (300 MHz, CDCl3): δ13.11 (brs, 1H, ▬NH), 8.19  
(s, 1H, Ar-H), 7.60 (d, J = 9.5 Hz, 2H, Ar-H), 7.54 (d, J = 9.4 Hz, 4H, Ar-H), 7.30 
(d, J = 8.6 Hz, 4H, Ar-H), 7.22 (d, J = 8.1 Hz, 2H, Ar-H), 5.80–5.78 (m, 2H, 〓CH), 
4.92 (d, J = 5.2 Hz, 1H, CH-S), 4.52 (s, 2H, OCH2), 4.06–3.94 (m, 2H, 2XCH), 3.80 
(t, 2H, OCH2), 3.68 (s, 6H, OCH3), 3.54 (s, 1H, CH): 
13CNMR (75 MHz, CDCl3): 
δ170.9, 162.1, 155.4, 144.2, 139.8, 134.6, 129.5, 125.8, 124.1, 122.0, 119.2, 115.4, 
86.1, 72.5, 64.4, 53.5, 44.8, 34.9: MS: m/z (M++Na) 781. Anal. Calcd for C33H30Cl2 
FN6O6PS: C, 52.18; H, 3.98, N, 11.06; Found: C, 51.91, H, 3.65. N, 10.86.
Dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-8-(4-nitrophenyl)-9-oxo-6-thia-
1,2,8-triazaspiro[4.4]non-2-en-3-ylphosphonate (11c): mp: 231–233°C, Yield—82%. 
1HNMR (300 MHz, CDCl3): δ13.06 (brs, 1H, ▬NH), 8.23 (d, J = 8.7 Hz, 2H, Ar-H), 
8.06 (s, 1H, Ar-H), 7.65 (d, J = 9.1 Hz, 2H, Ar-H), 7.51 (d, J = 9.4 Hz, 2H, Ar-H), 7.41 
(d, J = 8.5 Hz, 2H, Ar-H), 7.10 (d, J = 8.3 Hz, 2H, Ar-H), 6.64 (d, J = 9.8 Hz, 2H, Ar-H), 
5.76–5.59 (m, 2H, 〓CH), 4.86 (d, J = 5.2 Hz, 1H, CH-S), 4.35 (s, 2H, OCH2), 4.01–3.93 
(m, 2H, 2XCH), 3.72 (s, 6H, OCH3), 3.65 (d, J = 6.9 Hz, 2H, OCH2), 3.45 (s, 1H, CH), 
13CNMR (75 MHz, CDCl3): δ171.1, 162.1, 150.0, 147.8, 144.0, 136.8, 131.4, 128.8, 127.2, 
122.0, 119.5, 115.4, 86.4, 72.4, 65.9, 63.9, 53.5, 44.5, 34.8: MS: m/z (M++H) 780. Calcd 
for C33H30ClFN7O8PS: C, 51.47; H, 3.93, N, 12.73; Found: C, 51.18, H, 3.55. N, 12.49.
Dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-9-oxo-8-o-tolyl-6-thia-1,2,8-tri-
azaspiro[4.4]non-2-en-3-ylphosphonate (11d): mp: 221–223°C, Yield—75%. 1HNMR 
(300 MHz, CDCl3): δ13.10 (brs, 1H, ▬NH), 8.02 (s, 1H, Ar-H), 7.59 (d, J = 8.5 Hz, 2H, 
Ar-H), 7.59 (d, J = 9.2 Hz, 2H, Ar-H), 7.44 (d, J = 8.7 Hz, 2H, Ar-H), 7.42–7.40  
(m, 4H, Ar-H), 7.12 (d, J = 9.1 Hz, 2H, Ar-H), 5.76 (m, 2H, 〓CH), 4.92 (d, J = 5.2 Hz, 
1H, CHS), 4.62 (s, 2H, OCH2), 4.09–3.99 (m, 2H, CH), 3.74 (s, 6H, OCH3), 3.62  
(s, 1H, CH), 3.80 (t, 2H, OCH2), 2.12 (s, 3H, CH3): 
13CNMR (75 MHz, CDCl3): δ170.4, 
160.1, 155.1, 144.4, 138.6, 136.2, 134.3, 130.7, 128.6, 127.2, 122.0, 119.2, 116.9, 115.4, 86.1, 
72.8, 63.8, 53.5, 44.9, 34.8, 17.9: MS: m/z (M++H) 739. Anal. Calcd for C34H33ClFN6O6S: 
C, 55.25; H, 4.50, N, 11.37; Found: C, 55.01, H, 4.25. N, 11.09.
Compound R Mol. formula Reaction time Yield %
A 
(hours)
B 
(minutes)
A B
11a C6H5 C33H31ClFN6O6PS 3.5 6 62 89
11b 4-Cl-C6H4 C33H30Cl2FN6O6PS 2.5 4 60 85
11c 4-NO2-C6H4 C33H30ClFN7O8PS 2.0 5 61 84
11d 2-CH3-C6H4 C34H33ClFN6O6PS 3.0 6 65 86
11e 4-CH3-C6H4 C34H33ClFN6O6PS 3.2 4 69 85
11f 3-OH-C6H4 C35H31ClFN6O7PS 2.0 5 72 89
11g 4-OH-C6H4 C35H35ClFN6O7PS 3.0 4 71 82
A: conventional method; B: microwave irradiation method.
Table 2. 
Synthesis of phosphonyl pyrazoles 11(a–g).
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Dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-9-oxo-8-p-tolyl-6-thia-1,2,8-
triazaspiro[4.4]non-2-en-3-ylphosphonate (11e): mp: 209–211°C, Yield—76%. 
1HNMR (300 MHz, CDCl3): δ13.01 (brs, 1H, ▬NH), 8.07 (s, 1H, Ar-H), 7.62  
(d, J = 9.1 Hz, 2H, Ar-H), 7.50 (d, J = 9.2 Hz, 2H, Ar-H), 7.40 (d, J = 8.7 Hz, 2H, 
Ar-H), 7.32 (d, J = 8.2 Hz, 2H, Ar-H), 7.18 (d, J = 8.8 Hz, 2H, Ar-H), 6.70  
(d, J = 9.4 Hz, 2H, Ar-H), 5.60–5.59 (m, 2H, 〓CH), 4.90 (s, 1H, CHS), 4.45 (s, 2H, 
OCH2), 4.01–3.99 (m, 2H, CH), 3.94 (t, 2H, OCH2), 3.75 (s, 6H, OCH3), 3.62  
(s, 1H, CH), 2.30 (s, 3H, CH3): 
13CNMR (75 MHz, CDCl3): δ170.9, 160.1, 155.0, 
144.1, 138.7, 136.8, 133.4, 130.4, 129.1, 127.2, 122.0, 119.1, 115.3, 86.1, 72.9, 68.1, 63.9, 
53.5, 44.5, 34.8, 21.6: MS: m/z (M++H) 739. Anal. Calcd for C31H26ClFN4O3S:  
C, 55.25; H, 4.50, N, 11.37; Found: C, 54.98, H, 4.25. N, 11.03.
Dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-8-(3-hydroxyphenyl)-9-oxo-
6-thia-1,2,8-triazaspiro[4.4]non-2-en-3-ylphosphonate (11f ): mp: 228–229°C, 
Yield—88%. 1H-NMR (300 MHz, CDCl3): δ13.09 (brs, 1H, ▬NH), 9.40  
(brs, 1H, Ph-OH), 8.04 (s, 1H, Ar-H), 7.61 (d, J = 9.7 Hz, 2H, Ar-H), 7.52  
(d, J = 9.3 Hz, 2H, Ar-H), 7.42 (d, J = 8.6 Hz, 2H, Ar-H), 7.13 (d, J = 8.4 Hz, 2H, 
Ar-H), 6.70–6.68 (m, 4H, Ar-H), 5.73–5.70 (m, 2H, =CH), 4.82 (d, J = 5.2 Hz, 1H, 
CHS), 4.54 (s, 2H, OCH2), 4.14 (t, 2H, OCH2), 4.0–3.97 (m, 2H, CH), 3.70  
(s, 6H, OCH3), 3.57 (s, 1H, CH): 
13CNMR (75 MHz, CDCl3): δ170.2, 156.1, 155.2, 
144.8, 136.8, 129.6, 128.2, 127.5, 122.4, 119.4, 115.4, 106.5, 86.4, 72.5, 66.4, 63.4, 53.5, 
44.9, 34.3: MS: m/z (M++H) 741. Anal. Calcd for C33H31ClFN6O7PS: C, 53.48;  
H, 4.22, N, 11.34; Found: C, 53.18, H, 4.01. N, 11.13.
Dimethyl 7-((2S,3S)-3-((1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)methoxy)-
3,6-dihydro-2H-pyran-2-yl)-4-(4-fluorophenyl)-8-(4-hydroxyphenyl)-9-oxo-
6-thia-1,2,8-triazaspiro[4.4]non-2-en-3-ylphosphonate (11g): mp: 293–295°C, 
Yield—69%. 1H-NMR (300 MHz, CDCl3): δ12.85 (brs, 1H, ▬NH), 9.32  
(brs, 1H, Ph-OH), 8.02 (s, 1H, Ar-H), 7.65 (d, J = 9.3 Hz, 2H, Ar-H), 7.59  
(d, J = 9.2 Hz, 2H, Ar-H), 7.49 (d, J = 8.4 Hz, 2H, Ar-H), 7.30 (d, J = 8.6 Hz, 2H, Ar-H), 
7.16 (d, J = 8.3 Hz, 2H, ArH), 7.0 (d, J = 8.8 Hz, 2H, Ar-H), 5.89–5.82 (m, 2H, 〓CH), 
4.96 (d, J = 5.4 Hz, 1H, CHS), 4.56 (s, 2H, OCH2), 4.07 (d, J = 2H, OCH2), 4.02–3.99 
(m, 2H, CH), 3.82 (s, 6H, OCH3), 3.62 (s, 1H, CH), 
13CNMR (75 MHz, CDCl3): 
δ172.9, 160.5, 154.3, 144.6, 136.2, 134.9, 134.3, 130.4, 129.8, 127.2, 125.6, 123.2, 119.8, 
116.1, 86.4, 73.6, 66.5, 64.0, 53.6, 44.8, 34.9: MS: m/z (M++Na) 763. Anal. Calcd for 
C33H31ClFN6O7PS: C, 53.48; H, 4.22, N, 11.34; Found: C, 53.18, H, 3.99. N, 11.13.
5. Conclusion
In conclusion, a series of a new class of hybrid heterocyclic’s 11a–g has been 
synthesized. The nematicidal activity of these compounds was evaluated against 
Dietylenchus myceliophagus and Caenorhabditis elegans. Among synthesized com-
pounds 11b, 11c, 11f and 11g are the most effective against Dietylenchus myceliopha-
gus and Caenorhabditis elegans the other test compounds showed moderate activity.
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